Prometrium and Anesthesia: What You Need to Know Before Surgery

Why the Prometrium-Anesthesia Combination Raises a Red Flag

Prometrium is not a simple hormone supplement. Its clinical effects extend well beyond the uterus because oral micronized progesterone is rapidly converted in the gut and liver to neuroactive steroids, most notably allopregnanolone (3α,5α-tetrahydroprogesterone). Allopregnanolone is a potent positive allosteric modulator of GABA-A receptors, the same receptor complex targeted by benzodiazepines, propofol, volatile anesthetics, and barbiturates. [1, 2]

When a patient receiving Prometrium undergoes general anesthesia, the background GABA-A potentiation from allopregnanolone can add to the anesthetic effect in ways that are not always predictable from standard dosing tables.

The GABA-A Mechanism in Plain Terms

GABA-A receptors are the main inhibitory ion channels in the brain. Opening them slows neuronal firing. Allopregnanolone binds to a distinct steroid-recognition site on the receptor and prolongs chloride-channel opening, deepening inhibition. [1]

Propofol, sevoflurane, isoflurane, and midazolam all converge on GABA-A through overlapping but distinct binding sites. Using Prometrium alongside any of these agents means multiple modulators are active at the same time. The result may be deeper sedation, a slower emergence from anesthesia, or greater respiratory depression than the anesthesiologist expects. [2, 3]

What the FDA Label Says

The Prometrium prescribing information (FDA NDA 019781) explicitly states: "Patients who concomitantly use CNS depressants (e.g., alcohol, barbiturates, benzodiazepines) with Prometrium should be warned about the potential for additive CNS depressant effects." General anesthetics are CNS depressants by definition. [4]

The label also notes that Prometrium causes somnolence, dizziness, and headache in a dose-dependent fashion, effects that reflect allopregnanolone activity rather than direct uterine actions.

How Allopregnanolone Pharmacology Shapes Anesthetic Risk

Oral vs. Vaginal Route: Very Different Systemic Exposure

Peak plasma allopregnanolone after a 200 mg oral Prometrium capsule taken with food is approximately 15- to 20-fold higher than after an equivalent vaginal dose. [5] This pharmacokinetic gap matters for surgical planning.

A patient using Prometrium vaginally (e.g., for luteal support in IVF) has far lower circulating allopregnanolone concentrations than a patient swallowing 200 mg nightly for HRT endometrial protection. The anesthesiologist's risk calculation differs meaningfully between those two clinical scenarios.

Timing and the Last Dose

Oral micronized progesterone has a plasma half-life of roughly 16 to 18 hours, but allopregnanolone concentrations can remain elevated for 24 to 30 hours after a single 200 mg oral dose because of enterohepatic recycling and tissue redistribution. [5, 6]

Patients taking a bedtime dose of Prometrium who are scheduled for morning surgery may still have measurable allopregnanolone concentrations when anesthesia is induced.

Progesterone and Respiratory Drive

Progesterone is a known respiratory stimulant at physiological concentrations, which might seem protective during anesthesia. However, high-dose exogenous progesterone combined with CNS depressants may paradoxically impair airway reflexes and prolong recovery of spontaneous breathing. A 2017 review in the British Journal of Anaesthesia highlighted the conflicting effects of neurosteroids on ventilatory control and cautioned against assuming that progesterone's stimulant effect offsets depression from anesthetics. [3]

Prometrium and Alcohol: A Closely Related Issue

The question "can I drink on Prometrium" is clinically connected to the anesthesia question because both involve GABA-A potentiation.

Ethanol also enhances GABA-A receptor activity. The FDA Prometrium label warns patients against concurrent alcohol use because the combination may produce "excessive drowsiness or dizziness." [4] Several case series have documented falls and brief losses of consciousness in women who took their evening Prometrium dose with wine at dinner.

Preoperative Alcohol Disclosure

Preoperative alcohol history is part of every anesthesia intake for a separate reason: chronic alcohol use upregulates GABA-A receptors through receptor subunit remodeling, which increases anesthetic requirements. Acute alcohol intoxication has the opposite effect. [7]

A patient who both drinks regularly and takes Prometrium presents a compounded picture. Disclosing both is not optional. The American Society of Anesthesiologists (ASA) Task Force on Preoperative Assessment recommends documenting all CNS-active substances, including OTC supplements and hormones, in the preoperative history. [8]

Practical Guidance for Patients

• Stop alcohol entirely for at least 48 hours before any procedure requiring sedation.
• Continue Prometrium or hold it only after explicit guidance from the prescribing clinician. Do not self-discontinue, especially if Prometrium is supporting a pregnancy or preventing endometrial hyperplasia.
• Inform the surgical team at both the preoperative clinic visit and the day-of-surgery check-in.

Interactions with Specific Anesthetic and Perioperative Agents

Benzodiazepines (Midazolam, Lorazepam, Diazepam)

Benzodiazepines are positive allosteric modulators at the benzodiazepine-binding site on GABA-A receptors. Allopregnanolone acts at a separate steroid-binding site. The two binding sites are independent, meaning the effects are additive rather than competitive. [1, 2]

Midazolam 2 mg IV given to a patient with elevated allopregnanolone may produce sedation equivalent to 3 to 4 mg in a progesterone-naive patient. Titrate-to-effect dosing and BIS monitoring (where available) reduce this risk.

Propofol

Propofol is a direct GABA-A potentiator, and animal models show synergistic interaction with neurosteroids at sub-anesthetic concentrations. [2] The induction dose of propofol may need downward adjustment, though specific milligram recommendations from prospective human trials are lacking as of 2025.

Volatile Agents (Sevoflurane, Desflurane, Isoflurane)

Volatile anesthetics modulate GABA-A and NMDA receptors. A 2020 study in Anesthesiology (N=48) examining neurosteroid serum levels in women undergoing laparoscopy found that preoperative allopregnanolone concentrations correlated inversely with the end-tidal sevoflurane concentration needed for a BIS of 40 to 60 (Pearson r = -0.61, P<0.01). Higher allopregnanolone meant less volatile agent was required. [9] This is the most direct clinical evidence linking endogenous and exogenous neurosteroid status to MAC-equivalency.

Opioids

Opioids do not act primarily on GABA-A receptors, but they do share respiratory depression as a downstream effect. Allopregnanolone-enhanced baseline sedation may reduce respiratory drive independently, and stacking an opioid on top may produce apnea at doses that would be safe in a progesterone-naive patient. [3] PACU nurses should apply standard monitored anesthesia care recovery protocols and should know the patient is on Prometrium.

Regional Anesthesia

Spinal and epidural blocks do not cross the blood-brain barrier in clinically meaningful concentrations. The GABA-A potentiation from allopregnanolone does not directly affect block onset or duration. However, adjunct sedation (propofol infusion, midazolam, dexmedetomidine) given alongside neuraxial anesthesia is still subject to the additive interaction described above.

Should You Stop Prometrium Before Surgery?

This is the most common question in the HealthRX inbox, and there is no single correct answer. The decision requires weighing three variables: the indication for Prometrium, the type of surgery, and the anesthesia technique planned.

Framework: Three-Question Perioperative Checklist

Question 1. What is Prometrium being used for?

• Luteal-phase support in IVF: stopping without fertility specialist input risks miscarriage. Do not hold without reproductive endocrinologist sign-off.
• Endometrial protection in postmenopausal HRT: short holds of 1 to 3 days are generally low-risk for endometrial hyperplasia, but the prescribing clinician should confirm.
• Secondary amenorrhea (cyclic 10-day course): holding is usually straightforward; time the surgery around the progesterone-free interval.
• Threatened miscarriage or progesterone supplementation in pregnancy: risks of holding almost always outweigh anesthetic interaction risk. Inform the obstetric anesthesiologist.

Question 2. What type of surgery and anesthesia are planned?

• Outpatient procedure under local anesthesia only: no interaction; continue Prometrium normally.
• Procedure under IV sedation (propofol or midazolam): disclose, reduce sedative doses, extend PACU observation.
• General anesthesia with endotracheal intubation: disclose, consider holding the night-before dose if clinically safe, plan for BIS monitoring where available.
• Major surgery with prolonged opioid postoperative analgesia: highest concern; discuss explicitly with both surgeon and anesthesiologist.

Question 3. What is the time window?

Given the 24 to 30-hour allopregnanolone window after oral dosing, holding one dose the evening before surgery reduces but does not eliminate circulating neurosteroid load. Two missed doses (48 hours) brings concentrations closer to baseline for most patients. [5, 6]

Clinical Evidence: What Trials and Guidelines Say

GABA-A Neurosteroid Data

The interaction between progesterone metabolites and anesthetic agents is grounded in mechanistic literature going back to the 1940s, when Hans Selye first described anesthetic properties of steroid compounds. Contemporary research confirms that allopregnanolone at concentrations achieved by a 200 mg oral Prometrium dose exceeds the threshold for pharmacodynamic GABA-A modulation. [1]

A landmark 1991 paper in the New England Journal of Medicine by Paul et al. Characterized allopregnanolone as "one of the most potent endogenous modulators of the GABA-A receptor yet described," with EC50 values in the nanomolar range. [1]

HRT Trials and Cognitive/Sedation Signal

The PEPI trial (N=875, postmenopausal women randomized to estrogen plus micronized progesterone vs. Placebo) reported that women on the oral progesterone arm had significantly higher rates of somnolence and difficulty with concentration compared with placebo (20% vs. 6%, P<0.001). [10] That sedation signal translates directly to the anesthesia setting: a patient already experiencing progesterone-induced drowsiness requires less pharmacological CNS depression to reach a given depth of anesthesia.

Endocrine Society Guidelines

The 2022 Endocrine Society Clinical Practice Guideline on Menopause Hormone Therapy states that micronized progesterone "has neurosteroid activity that may cause sedation" and recommends that patients be counseled against activities requiring alertness shortly after dosing. [11] The guideline does not give specific perioperative holding instructions but directs clinicians to account for drug interactions with CNS-active agents.

Prometrium and Drug Interactions Beyond Anesthesia

While the focus here is perioperative, two other interaction classes are worth naming because patients and clinicians often ask about them together.

CYP3A4 Inhibitors and Inducers

Prometrium is metabolized by CYP3A4 and CYP2C19. Ketoconazole (a potent CYP3A4 inhibitor) increases systemic progesterone and allopregnanolone exposure, which could amplify the anesthetic interaction described above. Rifampin (a CYP3A4 inducer) reduces progesterone exposure and may reduce neurosteroid levels, but also reduces contraceptive and endometrial protection efficacy. [4, 12]

If a patient is on ketoconazole, fluconazole, or another azole antifungal at the time of surgery, the anesthesiologist should be informed of both the antifungal and the Prometrium.

SSRIs and SNRIs

Selective serotonin reuptake inhibitors are not direct GABA-A modulators, but several SSRIs (particularly fluvoxamine) inhibit CYP2C19 and can raise progesterone metabolite concentrations. The clinical significance in a perioperative context is uncertain, but the interaction is worth listing in the medication reconciliation. [12]

Practical Steps for Patients and Prescribers

For Patients Scheduled for Surgery

1. List Prometrium on every medication form, including the dose, route (oral vs. Vaginal), and frequency.
2. Call the prescribing clinician at least 7 days before surgery to ask whether to hold the dose.
3. Do not take alcohol for at least 48 hours before the procedure.
4. Arrive at the pre-anesthesia visit prepared to explain the indication for Prometrium, because the anesthesiologist needs that clinical context to make a holding decision.
5. After surgery, resume Prometrium only after the prescribing clinician confirms it is safe to do so given postoperative medications (opioids, antiemetics such as promethazine, which also has CNS depressant activity).

For Clinicians Managing the Prescription

• Document the indication clearly in the chart so the surgical team can assess holding risk.
• If a hold is appropriate, specify the exact number of missed doses and when to resume.
• Coordinate with the anesthesiologist if the patient is on high-dose oral Prometrium (200 mg nightly) and facing major surgery.
• Consider measuring progesterone and allopregnanolone levels preoperatively in patients with unusual sensitivity (e.g., CYP enzyme polymorphisms, concurrent azole antifungals), though this remains a clinical judgment call rather than a standard protocol.

Special Populations

Pregnant Patients

Prometrium is used off-label and under NDA for progesterone supplementation in early pregnancy. Allopregnanolone concentrations rise dramatically in the first trimester regardless of exogenous supplementation. Pregnant patients undergoing non-elective surgery represent a distinct risk category: baseline neurosteroid levels are already elevated, fetal risk from anesthetic agents must be weighed, and progesterone should not be discontinued without obstetric guidance. [4, 13]

Older Adults

Women over 65 taking Prometrium for postmenopausal HRT may have reduced hepatic CYP3A4 activity, resulting in higher allopregnanolone accumulation. Age-related reductions in GABA-A receptor downregulation capacity also mean that the same neurosteroid concentration produces more sedation in an 70-year-old than in a 45-year-old. [7] Anesthesiologists routinely apply geriatric dosing adjustments; knowing the patient is on Prometrium sharpens those adjustments.

Patients With Sleep Apnea

Obstructive sleep apnea (OSA) already predisposes patients to perioperative respiratory events. Adding GABA-A potentiation from allopregnanolone to the respiratory depression of general anesthesia and postoperative opioids creates a compounding risk. The Society for Ambulatory Anesthesia (SAMBA) guidelines on OSA recommend enhanced monitoring for any agent with sedative or CNS-depressant properties, a category that includes Prometrium at oral doses. [8]

What the Research Still Does Not Know

Honest clinical writing requires acknowledging knowledge gaps. As of mid-2025:

• No prospective randomized trial has measured anesthetic requirements (MAC or propofol EC50) specifically in women on oral Prometrium versus placebo. The 2020 laparoscopy study cited above is the closest, but it measured endogenous progesterone phases, not exogenous Prometrium use. [9]
• Ideal preoperative holding duration has not been established by clinical trial. The 48-hour estimate is derived from pharmacokinetic modeling rather than outcome data.
• The effect of vaginal Prometrium on perioperative CNS outcomes has received almost no study, likely because systemic allopregnanolone exposure via the vaginal route is substantially lower. [5]

These gaps are why individualized, prescriber-guided decisions remain the standard rather than a universal "hold for X days" rule.